Lexaria to Present at H.C. Wainwright Conference
Analysis based on 6 articles · First reported Sep 04, 2026 · Last updated Sep 04, 2026
The announcement is a routine corporate development with minimal direct market impact. It may modestly increase visibility among investors but is unlikely to significantly affect Lexaria's stock price.
Lexaria Bioscience Corp., a drug delivery platform company, announced it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, scheduled for September 14-16, 2026 in New York City. CEO Bong Go will deliver a company presentation and hold one-on-one investor meetings. The event provides Lexaria with an opportunity to showcase its DehydraTECH technology and engage with potential investors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard